IN170846B - - Google Patents

Info

Publication number
IN170846B
IN170846B IN185/CAL/90A IN185CA1990A IN170846B IN 170846 B IN170846 B IN 170846B IN 185CA1990 A IN185CA1990 A IN 185CA1990A IN 170846 B IN170846 B IN 170846B
Authority
IN
India
Application number
IN185/CAL/90A
Other languages
English (en)
Inventor
Csaba Molnar
Dr Gyorgy Hajos
Dr Laszlo Szporny
Dr Jozsef Toth
Dr Arpad Kiraly
Dr Anna Boor
Janos Csorgei
Krisztina Szekely
Dr Lilla Forgacs
Dr Gyorgy Fekete
Bulcsu Herenyi
Dr Sandor Holly
Dr Jozsef Szunyog
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of IN170846B publication Critical patent/IN170846B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN185/CAL/90A 1989-03-09 1990-02-28 IN170846B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU891156A HU203562B (en) 1989-03-09 1989-03-09 Process for producing new steroide diols and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
IN170846B true IN170846B (de) 1992-05-30

Family

ID=10953088

Family Applications (1)

Application Number Title Priority Date Filing Date
IN185/CAL/90A IN170846B (de) 1989-03-09 1990-02-28

Country Status (17)

Country Link
US (1) US5082835A (de)
EP (1) EP0387091A3 (de)
JP (1) JPH06104679B2 (de)
KR (1) KR930009445B1 (de)
CN (1) CN1045396A (de)
AR (1) AR244700A1 (de)
AU (1) AU623503B2 (de)
CA (1) CA2011282A1 (de)
EG (1) EG19411A (de)
FI (1) FI901199A0 (de)
HU (1) HU203562B (de)
IL (1) IL93478A (de)
IN (1) IN170846B (de)
NO (1) NO177147C (de)
PH (1) PH26676A (de)
PT (1) PT93375A (de)
ZA (1) ZA901752B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
FR2675146A1 (fr) * 1991-04-10 1992-10-16 Roussel Uclaf Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
CN110078785A (zh) * 2019-06-04 2019-08-02 博诺康源(北京)药业科技有限公司 一种布地奈德杂质ep-ze的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3167545A (en) * 1959-02-07 1965-01-26 Syntex Corp 16beta-methyl-16alpha, 17 alpha-dihydroxy pregnenes and the 16alpha, 17alpha-cyclic ketals and acetals thereof
US3345362A (en) * 1961-07-27 1967-10-03 Lilly Co Eli Novel pregnenolone acetonides
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
DE3878463T2 (de) * 1987-08-14 1993-06-24 Upjohn Co Verfahren zur 9-alpha-dehalogenierung von 9-alpha-steroiden.

Also Published As

Publication number Publication date
FI901199A0 (fi) 1990-03-09
NO177147B (no) 1995-04-18
KR930009445B1 (ko) 1993-10-04
NO177147C (no) 1995-07-26
EP0387091A3 (de) 1992-05-06
JPH02279695A (ja) 1990-11-15
IL93478A0 (en) 1990-11-29
EP0387091A2 (de) 1990-09-12
CN1045396A (zh) 1990-09-19
HU203562B (en) 1991-08-28
NO901103L (no) 1990-09-10
IL93478A (en) 1994-11-11
AU5110290A (en) 1990-09-13
NO901103D0 (no) 1990-03-08
AR244700A1 (es) 1993-11-30
JPH06104679B2 (ja) 1994-12-21
KR900014422A (ko) 1990-10-23
ZA901752B (en) 1991-05-29
PT93375A (pt) 1990-11-07
US5082835A (en) 1992-01-21
CA2011282A1 (en) 1990-09-09
PH26676A (en) 1992-09-15
AU623503B2 (en) 1992-05-14
EG19411A (en) 1995-01-31

Similar Documents

Publication Publication Date Title
DK0407615T3 (de)
EP0679974A3 (de)
EP0426507A3 (de)
FR2643171B1 (de)
FR2645293B1 (de)
ATA190290A (de)
FR2644718B1 (de)
FR2653503B1 (de)
FR2651526B1 (de)
FR2652918B1 (de)
FR2645988B1 (de)
DE4090195T (de)
FR2669514B1 (de)
FR2642774B1 (de)
DE4091474T (de)
FR2643457B1 (de)
IN170846B (de)
IN169862B (de)
FR2652627B1 (de)
FR2653769B1 (de)
DE4091342T (de)
DE4092178T (de)
DE4091095T (de)
FR2661690A3 (de)
FR2648372B1 (de)